Rx Percorten-V 25mg/ml injection x 4 ml bottle

Percorten-VPercorten-V (desoxycorticosterone pivalate injectable suspension) the first FDA approved treatment for canine Addison’s disease (hypodrenocorticism). For use as replacement therapy for the mineral corticoid deficit in dogs with primary adrenocoritcol insufficiency Treats Addison's disease (hypoadrenocorticism) in dogsIntramuscular injectable suspension for dogs onlyRequires a prescription from a licensed veterinarian to be purchased All prescription items are Non-Refundable and Non-Returnable. Manufacturer Name: Novartis Animal Health US, Inc. - CAUTIONS/WARNINGS:Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Warning: Do not use this drug in pregnant dogs. Do not use in dogs suffering from congestive heart disease, severe renal disease or edema. In case of human consumption, contact a physician or Poison Control Center immediately. Keep out of reach of children and animals. All prescription items are Non-Refundable and Non-Returnable. - DIRECTIONS:Dosage/Directions: Recommended dosages only. Always follow the directions for dosing and administration from your veterinarian. In treating canine hypoadrenocorticism, PERCORTEN-V replaces the mineralocorticoid hormones only. Glucocorticoid replacement must be supplied by small daily doses of glucocorticoid hormones (e.g., prednisone or prednisolone) (0.2 - 0.4 mg/kg/day). Dosage requirements are variable and must be individualized on the basis of the response of the patient to therapy. Begin treatment with PERCORTEN-V at a dose of 1.0 mg per pound of body weight every 25 days. In some patients the dose may be reduced. Serum sodium and potassium levels should be monitored to assure the animal is properly compensated. Most patients are well controlled with a dose range of 0.75 to 1.0 mg per pound of body weight, given every 21 to 30 days. Administration: Before injection, shake the vial thoroughly to mix the microcrystals with the suspension vehicle. PERCORTEN-V suspension is to be injected intramuscularly. Care should be used to prevent inadvertent intravenous injection, which may cause acute collapse and shock. Such animals should receive immediate therapy for shock with intravenous fluids and glucocorticoids.Once vial is broached, product should be used within 4 months. Storage Conditions: Store at room temperature, preferably between 15 and 30°C (59 and 86°F). Protect from light. Protect from freezing. - INGREDIENTS:Active Ingredients: Multiple-Dose Vials, 4 ml, each ml containing 25 mg desoxycorticosterone pivalate (DOCP), 10.5 mg methylcellulose, 3 mg sodium carboxymethylcellulose, 1 mg polysorbate 80, and 8 mg sodium chloride with 0.002% thimerosal added as preservative in water for injection. Packed one vial per carton. - STORAGE/DISPOSAL REQ:Store at 59-86 degrees F - HEIGHT(INCHES): 1.000 - WIDTH(INCHES):1.000 - LENGTH(INCHES):1.000